FDA DEVICE FACTS
Median LCS (internal name) / eyonis LCS (trade name) (1.0)
Median Technologies
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
eyonis® LCS is indicated for use by radiologists. eyonis® LCS assists radiologists in the detection, localization and characterization of solid and part-solid probably benign, suspicious and very suspicious pulmonary parenchymal nodules with a diameter of 4-30 mm (pure ground glass, mediastinal lesions and masses - including but not limited to hilar masses - are excluded). The eyonis® LCS - lung nodules result report provides, for each reported nodule, the following information: slice number, malignancy score, full snapshot, close-up snapshot, diameters (long/short/average) and volume. The eyonis® LCS - lung nodules result report is indicated to aid in diagnosis as well as to aid in follow-up exam evaluations and as an adjunct to support clinical/patient management. It cannot, however, substitute for medical experts' clinical judgment. The target population is high-risk patients eligible for participation in lung cancer screening programs (as per USPSTF criteria) with the exception of patients with pure ground glass cancer only and hilar/mediastinal cancer who are excluded from the intended population. It is indicated for use with low-dose Chest CT DICOM images. The exact specifications are described in a DICOM Conformance Statement (DCS) document.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。